ArticleClinical and molecular hepatology2020

Substantial risk of recurrence even after 5 recurrence-free years in early-stage hepatocellular carcinoma patients.

Jihye Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.